Electrical stimulation of cardiomyocytes activates mitochondrial matrix metalloproteinase causing electrical remodeling

Biochemical and Biophysical Research Communications

Volumn 404, Issue 3, 2011, Pages 762-766

  Vacek, Thomas P ^a   Metreveli, Naira ^a   Tyagi, Neetu ^a   Vacek, Jonathan C ^a   Pagni, Sebastian ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Arrhythmia; Calcium transient; Electrical pacing; Heart failure; SCD

Indexed keywords

MATRIX METALLOPROTEINASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; ENZYME ACTIVATION; HEART CONTRACTION; HEART MUSCLE CELL; HEART PACING; ISOLATED HEART; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ZYMOGRAPHY;

ANIMALS; CALCIUM; ELECTRIC STIMULATION; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MITOCHONDRIA, HEART; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC;

EID: 78751640563     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.12.039     Document Type: Article

References (25)

1. Ahtikoski A.M., Tuominen H., Korpelainen J.T., Takala T.E., Oikarinen A. Collagen synthesis and degradation in polyneuropathy and myopathies. Muscle Nerve 2004, 30:602-608.
2. Cornelussen R.N., Splett V., Klepfer R.N., Stegemann B., Kornet L., Prinzen F.W. Electrical modalities beyond pacing for the treatment of heart failure. Heart Fail. Rev. 2010.
3. Gao X., Xu X., Pang J., Zhang C., Ding J.M., Peng X., Liu Y., Cao J.M. NMDA receptor activation induces mitochondrial dysfunction, oxidative stress and apoptosis in cultured neonatal rat cardiomyocytes. Physiol. Res. 2007, 56:559-569.
4. Gill S.E., Parks W.C. Metalloproteinases and their inhibitors: regulators of wound healing. Int. J. Biochem. Cell Biol. 2008, 40:1334-1347.
5. Herrmann M., Taban-Shomal O., Hubner U., Bohm M., Herrmann W. A review of homocysteine and heart failure. Eur. J. Heart Fail. 2006, 8:571-576.
6. Hoit B.D., Takeishi Y., Cox M.J., Gabel M., Kirkpatrick D., Walsh R.A., Tyagi S.C. Remodeling of the left atrium in pacing-induced atrial cardiomyopathy. Mol. Cell Biochem. 2002, 238:145-150.
7. Lichtinghagen R., Seifert T., Kracke A., Marckmann S., Wurster U., Heidenreich F. Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis. J. Neuroimmunol. 1999, 99:19-26.
8. Lindsey M.L., Escobar G.P., Mukherjee R., Goshorn D.K., Sheats N.J., Bruce J.A., Mains I.M., Hendrick J.K., Hewett K.W., Gourdie R.G., Matrisian L.M., Spinale F.G. Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation 2006, 113:2919-2928.
9. Ma Y.S., Chen Y.C., Lu C.Y., Liu C.Y., Wei Y.H. Upregulation of matrix metalloproteinase 1 and disruption of mitochondrial network in skin fibroblasts of patients with MERRF syndrome. Ann. NY Acad. Sci. 2005, 1042:55-63.
10. Maier L.S., Bers D.M. Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond. J. Mol. Cell Cardiol. 2002, 34:919-939.
11. Makowski G.S., Ramsby M.L. Autoactivation profiles of calcium-dependent matrix metalloproteinase-2 and -9 in inflammatory synovial fluid: effect of pyrophosphate and bisphosphonates. Clin. Chim. Acta 2005, 358:182-191.
12. Moshal K.S., Kumar M., Tyagi N., Mishra P.K., Metreveli N., Rodriguez W.E., Tyagi S.C. Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H887-H892.
13. Moshal K.S., Sen U., Tyagi N., Henderson B., Steed M., Ovechkin A.V., Tyagi S.C. Regulation of homocysteine-induced MMP-9 by ERK1/2 pathway. Am. J. Physiol. Cell Physiol. 2006, 290:C883-C891.
14. Moshal K.S., Singh M., Sen U., Rosenberger D.S., Henderson B., Tyagi N., Zhang H., Tyagi S.C. Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC. Am J. Physiol. Heart Circ. Physiol. 2006, 291:H2825-H2835.
15. Moshal K.S., Tipparaju S.M., Vacek T.P., Kumar M., Singh M., Frank I.E., Patibandla P.K., Tyagi N., Rai J., Metreveli N., Rodriguez W.E., Tseng M.T., Tyagi S.C. Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H890-H897.
16. Nelson K.K., Melendez J.A. Mitochondrial redox control of matrix metalloproteinases. Free Radic. Biol. Med. 2004, 37:768-784.
17. Ni M., Zhang X.H., Jiang S.L., Zhang Y. Homocysteinemia as an independent risk factor in the Chinese population at a high risk of coronary artery disease. Am. J. Cardiol. 2007, 100:455-458.
18. Rucklidge G.J., Milne G., McGaw B.A., Milne E., Robins S.P. Turnover rates of different collagen types measured by isotope ratio mass spectrometry. Biochim. Biophys. Acta 1992, 1156:57-61.
19. Russo T.L., Peviani S.M., Durigan J.L., Salvini T.F. Electrical stimulation increases matrix metalloproteinase-2 gene expression but does not change its activity in denervated rat muscle. Muscle Nerve 2008, 37:593-600.
20. Sood H.S., Cox M.J., Tyagi S.C. Generation of nitrotyrosine precedes activation of metalloproteinase in myocardium of hyperhomocysteinemic rats. Antioxid. Redox Signal. 2002, 4:799-804.
21. Tyagi N., Mishra P.K., Tyagi S.C. Homocysteine, hydrogen sulfide (H2S) and NMDA-receptor in heart failure. Indian J. Biochem. Biophys. 2009, 46:441-446.
22. Tyagi N., Vacek J.C., Givvimani S., Sen U., Tyagi S.C. Cardiac specific deletion of N-methyl-d-aspartate receptor 1 ameliorates mtMMP-9 mediated autophagy/mitophagy in hyperhomocysteinemia. J. Recept. Signal Transduct. Res. 2010, 30:78-87.
23. Tyagi S.C., Meyer L., Schmaltz R.A., Reddy H.K., Voelker D.J. Proteinases and restenosis in the human coronary artery: extracellular matrix production exceeds the expression of proteolytic activity. Atherosclerosis 1995, 116:43-57.
24. Verkerk A.O., Wilders R., Zegers J.G., van Borren M.M., Ravesloot J.H., Verheijck E.E. Ca(2+)-activated Cl(-) current in rabbit sinoatrial node cells. J. Physiol. 2002, 540:105-117.
25. Ye G., Metreveli N.S., Donthi R.V., Xia S., Xu M., Carlson E.C., Epstein P.N. Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 2004, 53:1336-1343.